Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,224,024
  • Shares Outstanding, K 70,347
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 437 M
  • EBITDA $ 518 M
  • 60-Month Beta 1.37
  • Price/Sales 10.44
  • Price/Cash Flow 69.32
  • Price/Book 15.63

Options Overview Details

View History
  • Implied Volatility 33.01% (+2.53%)
  • Historical Volatility 45.30%
  • IV Percentile 35%
  • IV Rank 27.20%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 14) 9.71 (3.12%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 19
  • Volume Avg (30-Day) 350
  • Put/Call OI Ratio 1.33
  • Today's Open Interest 12,795
  • Open Int (30-Day) 13,225
  • Expected Range 300.99 to 320.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.48
  • Number of Estimates 10
  • High Estimate 1.86
  • Low Estimate 1.32
  • Prior Year 1.15
  • Growth Rate Est. (year over year) +28.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
290.16 +7.10%
on 11/06/25
354.88 -12.43%
on 11/20/25
-3.68 (-1.17%)
since 11/05/25
3-Month
288.02 +7.89%
on 10/01/25
354.88 -12.43%
on 11/20/25
-37.67 (-10.81%)
since 09/05/25
52-Week
230.05 +35.08%
on 03/10/25
354.88 -12.43%
on 11/20/25
+43.18 (+16.14%)
since 12/05/24

Most Recent Stories

More News
2 High-Flying Stocks with Impressive Fundamentals and 1 We Turn Down

2 High-Flying Stocks with Impressive Fundamentals and 1 We Turn Down

BE : 117.68 (-0.35%)
PODD : 309.85 (-1.92%)
FND : 63.98 (-1.49%)
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode...

PODD : 309.85 (-1.92%)
Is DexCom Stock Underperforming the S&P 500?

DexCom has considerably underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 6,874.93 (+0.26%)
PODD : 309.85 (-1.92%)
DXCM : 66.43 (+1.81%)
2 Growth Stocks with Explosive Upside and 1 We Find Risky

2 Growth Stocks with Explosive Upside and 1 We Find Risky

PODD : 309.85 (-1.92%)
GS : 850.02 (+1.45%)
PFS : 19.96 (-0.35%)
3 Quality Compounders to Keep an Eye On

3 Quality Compounders to Keep an Eye On

CPNG : 27.23 (+0.78%)
APH : 137.52 (-1.39%)
PODD : 309.85 (-1.92%)
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

GH : 104.00 (-4.17%)
AGL : 0.6755 (-7.21%)
EVH : 4.07 (+1.50%)
MYGN : 7.16 (-2.32%)
PODD : 309.85 (-1.92%)
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Company announces strong long-range financial outlook for 2025–2028 Introduces next-generation innovation pipeline to transform diabetes care

PODD : 309.85 (-1.92%)
Insulet Stock: Is Wall Street Bullish or Bearish?

Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s trajectory.

$SPX : 6,874.93 (+0.26%)
PODD : 309.85 (-1.92%)
IHI : 63.75 (+0.69%)
Stocks Supported by Strength in Megacap Tech and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.74%. December E-mini S&P...

AMAT : 270.76 (+0.49%)
MPC : 193.21 (+1.61%)
GOOGL : 320.21 (+0.82%)
GTLB : 38.27 (+2.03%)
AVGO : 387.48 (+1.69%)
CVX : 152.30 (+0.03%)
IRM : 84.81 (-0.26%)
ADI : 282.42 (+1.86%)
$IUXX : 25,689.43 (+0.42%)
ASML : 1,109.80 (-0.03%)
ZNH26 : 112-185 (-0.12%)
OXY : 43.11 (+1.03%)
Stock Indexes Gain on Strength in Alphabet and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.60%. December E-mini S&P futures...

AMAT : 270.76 (+0.49%)
MPC : 193.21 (+1.61%)
GOOGL : 320.21 (+0.82%)
GTLB : 38.27 (+2.03%)
CVX : 152.30 (+0.03%)
$IUXX : 25,689.43 (+0.42%)
ASML : 1,109.80 (-0.03%)
ZNH26 : 112-185 (-0.12%)
OXY : 43.11 (+1.03%)
AGIO : 27.23 (-0.69%)
ESZ25 : 6,880.75 (+0.20%)
FANG : 162.85 (+2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 332.78
2nd Resistance Point 325.06
1st Resistance Point 320.49
Last Price 309.85
1st Support Level 308.20
2nd Support Level 300.48
3rd Support Level 295.91

See More

52-Week High 354.88
Last Price 309.85
Fibonacci 61.8% 307.19
Fibonacci 50% 292.46
Fibonacci 38.2% 277.74
52-Week Low 230.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar